Incidence, etiology, risk factors, and outcomes of pre-engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation [0.03%]
首次和二次异基因造血细胞移植后植入前血液流感染的发生率、病原学、危险因素及结局分析
Mobil Akhmedov,Galina Klyasova,Larisa Kuzmina et al.
Mobil Akhmedov et al.
Introduction: With an increasing number of allogeneic hematopoietic cell transplantations (allo-HCT) bloodstream infections (BSI) are still among the most common and serious complications. This study aimed to analyze the ...
Rapid reinfection of severe acute respiratory syndrome coronavirus 2 confirmed with sequencing in a solid organ transplant recipient [0.03%]
移植受者中严重急性呼吸系统综合症冠状病毒2的快速再感染（通过测序确认）
Yoichiro Natori,David Andrews,Giselle Guerra
Yoichiro Natori
Pulmonary nocardiosis in a heart transplant recipient diagnosed with plasma next-generation sequencing [0.03%]
基于血浆下一代测序诊断的心脏移植受者肺诺卡菌病
Shilpa Vasishta,Timothy Sullivan
Shilpa Vasishta
Impact of pre-transplant bloodstream infection on clinical outcomes after heart transplantation [0.03%]
心脏移植前血流感染对移植后临床结局的影响
Jeng-Wei Chen,Heng-Wen Chou,Nai-Kuan Chou et al.
Jeng-Wei Chen et al.
Background: Active bloodstream infection (BSI) is a contraindication for heart transplantation (HT). However, some critical patients with BSI may undergo HT as a life-saving procedure. We aimed to investigate the impact o...
COVID-19 in vaccinated versus unvaccinated hematologic malignancy patients [0.03%]
接种与未接种疫苗的血液系统恶性肿瘤患者中的COVID-19状况
Catherine DeVoe,Shraddha Pandey,Dayana Shariff et al.
Catherine DeVoe et al.
The effect of vaccination on severity of subsequent COVID-19 in patients with hematologic malignancies (HMs) is unknown. In this single-center retrospective cohort study, we found no difference in severity of COVID-19 disease in vaccinated ...
Comment on: mRNA SARS-CoV-2 vaccination in patients after allogeneic hematopoietic cell transplantation [0.03%]
对allo-HCT患者接种新冠病毒mRNA疫苗的评论
R Mungmunpuntipantip,Viroj Wiwanitkti
R Mungmunpuntipantip
Comment on "Re-infection with SARS-CoV-2 in solid-organ transplant recipients" [0.03%]
对“实体器官移植受者出现冠状病毒再感染”的点评
Pathum Sookaromdee,Viroj Wiwanitkit
Pathum Sookaromdee
COVID-19 infection in renal transplant recipients in early post-renal transplantation period: Report of three cases [0.03%]
肾移植术后早期肾移植受者的新冠肺炎感染：3例报告
Tika Ram Bhandari,Kalpana Kumari Shrestha,Pukar Chandra Shrestha
Tika Ram Bhandari
Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis [0.03%]
同种异基因造血干细胞移植后人疱疹病毒6型DNA及染色体整合的检测：单中心回顾性分析
Laura Berneking,Anna Both,Claudia Langebrake et al.
Laura Berneking et al.
Introduction: Human herpesvirus 6 (HHV-6) can reactivate after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and may be associated with significant morbidity and mortality. ...
Antifungal prophylaxis in adult lung transplant recipients: Uncertainty despite 30 years of experience. A systematic review of the literature and network meta-analysis [0.03%]
肺移植受者抗真菌预防：三十年经验的不确定性。文献系统综述及网络meta分析
Tina Marinelli,Setareh Davoudi,Farid Foroutan et al.
Tina Marinelli et al.
Background: Invasive fungal infections (IFI), particularly invasive aspergillosis (IA), cause significant morbidity and mortality in lung transplant (LTx) recipients. The optimum strategy and antifungal agents for prevent...